News Headlines

Display #
Title
Zoetis to Acquire Nexvet Biopharma, an Innovator in Monoclonal Antibody Therapies for Companion Animals
Using Mobile to Drive Lift Throughout the Patient Engagement Journey
Trump administration issues final rule on stricter Obamacare enrollment
Abbott, Alere End Merger Legal Battle
’60 Minutes’ Fixes Lens on “Miracle Eye Doctors”
Leaning forward during phone use may cause ‘text neck’
FDA declines to approve arthritis drug Olumiant
Japan automakers look to robots to keep elderly on the move
FDA approves first drug to treat tardive dyskinesia
Roche launches antibody test to aid in diagnosis of challenging prostate cancer cases
BioMarin Announces Kuvan (sapropterin dihydrochloride) Patent Challenge Settlement
Brain tissue from a petri dish
Tech Giant Apple Hires Secret Team of Biomedical Engineers for Treating Diabetes
Icon Bioscience Submits NDA for Dexycu, a Potential Transformational Drug Therapy for Treating Inflammation Associated with Cataract Surgery
University of California files CRISPR patents appeal
NextGen Healthcare Announces Agreement to Acquire Entrada Inc.
Bristol-Myers Squibb enters into separate agreements with Biogen and Roche to License anti-eTau and anti-myostatin compounds
U.S. FDA raises concerns over Teva’s plant in China
Bristol-Myers licenses two drugs to Biogen, Roche
FDA warns Abbott Labs over heart devices
UK cost agency turns down Bristol drug
Health risk assessments shed light on early predictors of depression
The accidental discovery of LSD
FDA Picks Emulate for Organ Chip Technology
Austrian biotech Themis launches Zika vaccine clinical trial
SEC Cracks Down on “Fake Biotech News”
The Human Vaccines Project, Vanderbilt And Illumina Join Forces To Decode The Human Immunome
India’s Strand Life Sciences launches blood test to detect cancer
U.S. guidelines relax opposition to prostate cancer screening
PatientsLikeMe and Shire Pharmaceuticals collaborate to study rare genetic diseases